Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres.

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Non-Tuberculous Mycobacterial infections post-hematopoietic stem cell transplantation

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Daratumumab for PRCA after alloSCT

Retrospective Studies

Complications: non-infectious

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Outcomes of PT-CY in elderly AML/MDS

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Maria Queralt Salas

Immune Checkpoint Inhibitors for solid tumors after allogeneic stem cell transplantation

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Pre-transplantation diabetes and obesity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation

Retrospective Studies

Complications: GvHD

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Lars Klingen Gjaerde

Chronic GVHD over time - a multicenter retrospective study

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Steroid-free first line treatment of moderate and severe chronic GVHD - restrospective study

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Effects of donor clonal hematopoiesis in unrelated HSCT

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

F. Damm & J. Schetelig

Machine learning approach to estimate toxicity-related mortality following allogeneic HSCT

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Alberto Mussetti

Lung GvHD - Review of current practices

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

John Murray; Saskia Bos

EBMT patient engagement taskforce (PRO)

Closed Survey/Study

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Helene Schoemans